Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive human malignancies with an overall 5-year survival rate of <5%. Despite significant advances in treatment of the disease during the past decade, the median survival rate (∼6 months) has hardly improved, warranting th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaistha, B P, Honstein, T, Müller, V, Bielak, S, Sauer, M, Kreider, R, Fassan, M, Scarpa, A, Schmees, C, Volkmer, H, Gress, T M, Buchholz, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453723/
https://www.ncbi.nlm.nih.gov/pubmed/25137017
http://dx.doi.org/10.1038/bjc.2014.460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453723/
https://www.ncbi.nlm.nih.gov/pubmed/25137017
http://dx.doi.org/10.1038/bjc.2014.460

Ejemplares similares